Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,023 | 108 | 98.2% |
| Education | $89.57 | 3 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,589 | 25 | $0 (2024) |
| Gilead Sciences, Inc. | $1,181 | 20 | $0 (2024) |
| GENZYME CORPORATION | $553.83 | 4 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $357.81 | 8 | $0 (2024) |
| Allergan Inc. | $186.62 | 8 | $0 (2018) |
| Intuitive Surgical, Inc. | $157.58 | 1 | $0 (2017) |
| Madrigal Pharmaceuticals | $130.59 | 1 | $0 (2024) |
| Janssen Biotech, Inc. | $124.18 | 4 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $122.31 | 1 | $0 (2023) |
| BIOTRONIK INC. | $114.22 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $787.76 | 10 | ABBVIE INC. ($230.51) |
| 2023 | $769.07 | 8 | Gilead Sciences, Inc. ($333.30) |
| 2022 | $330.29 | 3 | ABBVIE INC. ($183.91) |
| 2021 | $111.75 | 2 | Gilead Sciences, Inc. ($87.41) |
| 2020 | $207.02 | 2 | Takeda Pharmaceuticals U.S.A., Inc. ($104.80) |
| 2019 | $730.54 | 22 | Gilead Sciences, Inc. ($292.56) |
| 2018 | $922.79 | 25 | AbbVie, Inc. ($478.55) |
| 2017 | $1,254 | 39 | AbbVie, Inc. ($440.46) |
All Payment Transactions
111 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/08/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $130.59 | General |
| Category: LIVER DISEASE | ||||||
| 11/05/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/29/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/26/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $139.31 | General |
| Category: Immunology | ||||||
| 08/14/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/18/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $108.20 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/28/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Education | In-kind items and services | $74.99 | General |
| Category: Immunology | ||||||
| 06/05/2024 | Olympus America Inc. | EVIS EXERA III COLONOVIDEOSCOPE (Device) | Food and Beverage | In-kind items and services | $31.92 | General |
| Category: Gastroenterology | ||||||
| 04/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $122.31 | General |
| Category: IMMUNOLOGY | ||||||
| 03/14/2024 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $122.31 | General |
| Category: HBV | ||||||
| 11/16/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $122.31 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/09/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $139.39 | General |
| Category: Immunology | ||||||
| 08/29/2023 | Olympus America Inc. | EndoClot SIS (Device) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: Endotherapy | ||||||
| 05/17/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: Oncology | ||||||
| 05/05/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $118.84 | General |
| 02/28/2023 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $122.31 | General |
| Category: HBV | ||||||
| 02/09/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $128.75 | General |
| Category: Immunology | ||||||
| 02/08/2023 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $92.15 | General |
| Category: HCV | ||||||
| 09/15/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $146.38 | General |
| Category: Immunology | ||||||
| 06/30/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $103.00 | General |
| Category: IMMUNOLOGY | ||||||
| 02/24/2022 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $80.91 | General |
| 11/10/2021 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $87.41 | General |
| Category: HBV | ||||||
| 04/01/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: NEUROSCIENCE | ||||||
| 01/30/2020 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $104.80 | General |
| Category: INTERNAL MEDICINE | ||||||
| 01/21/2020 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $102.22 | General |
| Category: HBV | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 734 | 797 | $741,815 | $77,331 |
| 2022 | 12 | 703 | 774 | $705,808 | $70,046 |
| 2021 | 14 | 834 | 906 | $846,546 | $83,147 |
| 2020 | 10 | 556 | 614 | $493,285 | $50,298 |
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 140 | 196 | $66,896 | $19,106 | 28.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 136 | 136 | $254,070 | $18,098 | 7.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 145 | 148 | $205,720 | $12,611 | 6.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 42 | 42 | $93,198 | $9,047 | 9.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 36 | 36 | $18,756 | $4,354 | 23.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 24 | 27 | $12,447 | $3,939 | 31.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 21 | 21 | $13,923 | $3,032 | 21.8% |
| 91010 | Study of esophagus to assess movement | Facility | 2023 | 45 | 45 | $13,545 | $2,310 | 17.1% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 11 | 11 | $17,567 | $2,084 | 11.9% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 13 | 13 | $15,938 | $1,162 | 7.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 13 | $3,042 | $617.12 | 20.3% |
| 91037 | Monitoring and recording of esophageal function through nasal tube with electrode | Facility | 2023 | 15 | 15 | $3,495 | $611.10 | 17.5% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2023 | 93 | 94 | $23,218 | $361.11 | 1.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 133 | 187 | $62,115 | $17,694 | 28.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 130 | 130 | $239,850 | $14,567 | 6.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 141 | 142 | $193,546 | $11,145 | 5.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 43 | 43 | $93,525 | $8,866 | 9.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 33 | 38 | $17,024 | $5,122 | 30.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 25 | 25 | $16,250 | $4,126 | 25.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 30 | 30 | $15,180 | $3,965 | 26.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 17 | 18 | $4,086 | $1,396 | 34.2% |
| 91010 | Study of esophagus to assess movement | Facility | 2022 | 24 | 24 | $7,008 | $1,312 | 18.7% |
| 43264 | Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | Facility | 2022 | 13 | 17 | $30,096 | $1,106 | 3.7% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2022 | 102 | 103 | $24,102 | $413.98 | 1.7% |
| 74328 | Review by radiologist of image from tube placement into bile duct using an endoscope | Facility | 2022 | 12 | 17 | $3,026 | $331.49 | 11.0% |
About De Tan
De Tan is a Gastroenterology healthcare provider based in Sacramento, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/24/2005. The National Provider Identifier (NPI) number assigned to this provider is 1851384044.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, De Tan has received a total of $5,113 in payments from pharmaceutical and medical device companies, with $787.76 received in 2024. These payments were reported across 111 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($5,023).
As a Medicare-enrolled provider, Tan has provided services to 2,827 Medicare beneficiaries, totaling 3,091 services with total Medicare billing of $280,821. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Sacramento, CA
- Active Since 08/24/2005
- Last Updated 12/20/2018
- Taxonomy Code 207RG0100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1851384044
Products in Payments
- DUPIXENT (Biological) $676.14
- Vemlidy (Drug) $557.65
- Humira (Biological) $343.39
- Mavyret (Drug) $274.58
- LINZESS (Drug) $263.94
- Entyvio (Biological) $260.42
- Epclusa (Drug) $209.37
- Creon (Drug) $186.05
- Da Vinci Surgical System (Device) $157.58
- RESMETIROM (Drug) $130.59
- ENTYVIO (Biological) $125.62
- STELARA (Biological) $124.18
- SKYRIZI (Biological) $122.31
- Viekira (Drug) $113.24
- RINVOQ (Biological) $103.00
- ZEPATIER (Drug) $98.48
- LifeVest (Device) $66.03
- Trulance (Drug) $45.49
- IBSRELA (Drug) $37.31
- UCERIS TABLETS (Drug) $32.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Sacramento
Dr. Joseph Leung, M.d, M.D
Gastroenterology — Payments: $382,939
Christopher Bowlus, M.d, M.D
Gastroenterology — Payments: $174,596
Dr. Antonio Mendoza Ladd, M.d, M.D
Gastroenterology — Payments: $84,349
Dr. Kuldeep Tagore, M.d, M.D
Gastroenterology — Payments: $53,535
Abdul Khaleq, Md, MD
Gastroenterology — Payments: $48,069
Dr. Valentina Medici, M.d, M.D
Gastroenterology — Payments: $30,237